A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive Disorder

NCT00368030 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

545

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia
Depressive Disorder, Major

Interventions

DRUG: Eszopiclone
OTHER: Placebo

Sponsor

Sumitomo Pharma America, Inc.